Navitor Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Navitor Pharmaceuticals Inc (Navitor Pharmaceuticals) is a biopharmaceutical company that develops medicines by targeting cellular nutrient signaling pathways. The company harnesses its proprietary drug discovery platform to develop selective modulators of the mTORC1 pathway. It develops mTORC1, a multi-protein complex, responds to and combines the cells reaction to nutrient availability and plays a crucial part in protein synthesis and cellular growth. The company designs drugs to regulate the irregular cellular signals in disease processes to treat a range of diseases including metabolic, neurodegenerative, autoimmune and musculoskeletal diseases. Navitor Pharmaceuticals is headquartered in Cambridge, Massachusetts, the US.

Navitor Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Navitor Pharma Raises USD11.3 Million in Venture Financing 10
Navitor Pharma Raises USD33 Million in Series B Financing 11
Navitor Pharma Raises USD24 Million in Series A Financing 13
Calorics Raises USD10.23 Million in Venture Financing 15
Partnerships 16
Navitor Pharma Enters into Agreement with X-Chem 16
Licensing Agreements 17
Navitor Pharma Exercises Option for Licensing Agreement with X-Chem 17
Navitor Pharmaceuticals Inc - Key Competitors 18
Navitor Pharmaceuticals Inc - Key Employees 19
Navitor Pharmaceuticals Inc - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Aug 02, 2018: Navitor Pharmaceuticals names Thomas E. Hughes as chief executive officer 21
Product News 22
Nov 09, 2017: Navitor Pharmaceuticals Scientific Founder Makes Seminal Discoveries Related to Role of Nutrient Sensors in mTOR Regulation and Activity 22
Clinical Trials 24
Nov 15, 2017: Navitor Pharmaceuticals to Develop NV-5138, a Specific Activator of mTORC1 for Treatment-Resistant Depression, Based on Promising Data Presented at Society for Neuroscience 2017 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List Of Tables


Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navitor Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Navitor Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Navitor Pharma Raises USD11.3 Million in Venture Financing 10
Navitor Pharma Raises USD33 Million in Series B Financing 11
Navitor Pharma Raises USD24 Million in Series A Financing 13
Calorics Raises USD10.23 Million in Venture Financing 15
Navitor Pharma Enters into Agreement with X-Chem 16
Navitor Pharma Exercises Option for Licensing Agreement with X-Chem 17
Navitor Pharmaceuticals Inc, Key Competitors 18
Navitor Pharmaceuticals Inc, Key Employees 19

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Navitor Pharmaceuticals Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Navitor Pharmaceuticals Inc (Navitor Pharmaceuticals) is a biopharmaceutical company that develops medicines by targeting cellular nutrient signaling pathways. The company harnesses its proprietary drug discovery platform to develop selective modulators

USD 250 View Report

Navitor Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Navitor Pharmaceuticals Inc (Navitor Pharmaceuticals) is a biopharmaceutical company that develops medicines by targeting cellular nutrient signaling pathways. The company harnesses its proprietary drug discovery platform to develop selective modulators

USD 250 View Report

EyePoint Pharmaceuticals Inc (PSDV) - Product Pipeline Analysis, 2019 Update

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert

USD 750 View Report

RespireRx Pharmaceuticals Inc (RSPI) - Strategic SWOT Analysis Review

RespireRx Pharmaceuticals Inc (RSPI) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available